B3-MED company became a Skolkovo resident

B3-MED has officially received the status of a resident of the Skolkovo Foundation. This was made possible by the successful participation in the Fast Track program and the defense of the project before the expert council, where the team demonstrated a high level of technological maturity and potential for scaling.

Our intelligent system, a digital tool for doctors that helps them choose diagnosis and treatment based on clinical recommendations, assess risks, and improve the effectiveness of therapy, has been highly praised for its innovation and practical relevance to healthcare.

The resident status provides B3-MED with access to Skolkovo’s infrastructure, new opportunities for scientific cooperation, and the support needed for further growth.

Scaling, partnership development, and implementation in medical practice across the country are ahead.